Switch to BIC/FTC/TAF - Slideset Download - AIDS 2019 | CCO
ARV-Trials.com
GS-US-380-1844 Study: Switch to BIC/FTC/TAF
Efficacy and safety of using bictegravir / emtricitabine / tenofovir alafenamide (BIC/FTC/TAF) in a test and treat model: the FAST Study
Randomized clinical trials of BIC/FTC/TAF and DTG/3TC in naïve patients. | Download Scientific Diagram
ARV-Trials.com
Etude SOLAR: la stratégie de switch vers CAB/RPV LA se révèle non inférieure à une poursuite de la trithérapie BIC/FTC/TAF - VIH - jm update Spécialiste - lejournaldumedecin.com
Randomized clinical trials of BIC/FTC/TAF and DTG/3TC in naïve patients. | Download Scientific Diagram
VIH : résultats à 96 semaines de phase 3 avec Biktarvy® de Gilead | MyPharma Editions
JCM | Free Full-Text | Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV
Qualified Health Plan Coverage for DTG/ABC/3TC and BIC/FTC/TAF by... | Download Scientific Diagram
ARV-Trials.com
ARV-Trials.com
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre
FTC/TAF + BIC Postexposure Prophylaxis Protects Macaques Against Rectal SHIV Infection
INSIGHT: Wk 24 Efficacy, Safety, and PK of BIC/FTC/TAF in Adults With HIV and Tuberculosis Receiving Rifampicin | CCO
Gilead's fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability - European Pharmaceutical Review
Efficacy and safety of using bictegravir / emtricitabine / tenofovir alafenamide (BIC/FTC/TAF) in a test and treat model: the FAST Study
Switch studies - ATAZIP study
Biomedicines | Free Full-Text | Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis
Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV | Infectious Diseases and Therapy
Switch studies - Etude ALIZE
Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study,Infectious Diseases and Therapy - X-MOL
